Clinical, biochemical, and genetic predictors of coronary artery bypass graft failure

Journal of Thoracic and Cardiovascular Surgery

Volumn 148, Issue 2, 2014, Pages

  Yanagawa, Bobby ^a   Algarni, Khaled D ^a,c   Singh, Steve K ^d   Deb, Saswata ^a   Vincent, Jessica ^a   Elituv, Randi ^a   Desai, Nimesh D ^e   Rajamani, Karthikeyan ^f   McManus, Bruce M ^f   Liu, Peter P ^g   Cohen, Eric A ^b   Radhakrishnan, Sam ^b   Dubbin, James D ^b   Schwartz, Leonard ^g   Fremes, Stephen E ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d HAMILTON HEALTH SCIENCES   (Canada)

^e Perelman Center for Advanced Medicine   (United States)

^f ST PAUL S HOSPITAL   (Canada)

^g TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; FIBRINOGEN; GLUTATHIONE TRANSFERASE A3; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CASE CONTROL STUDY; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GENE MUTATION; GENETICS; GRAFT FAILURE; GRAFT OCCLUSION; HEART PROTECTION; HUMAN; HUMAN TISSUE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOGENESIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIAL ARTERY; RISK FACTOR; SAPHENOUS VEIN; SINGLE NUCLEOTIDE POLYMORPHISM; STRATIFICATION;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CREATININE; FEMALE; FIBRINOGEN; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GLUTATHIONE TRANSFERASE; GRAFT OCCLUSION, VASCULAR; HUMANS; LIPOPROTEINS, HDL; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TREATMENT FAILURE; VASCULAR PATENCY;

EID: 84904656254     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.10.011     Document Type: Article

References (24)

1. F.D. Loop, B.W. Lytle, D.M. Cosgrove, R.W. Stewart, M. Goormastic, and G.W. Williams et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events N Engl J Med 314 1986 1 6
2. P. Greenland, M.D. Knoll, J. Stamler, J.D. Neaton, A.R. Dyer, and D.B. Garside et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events JAMA 290 2003 891 897
3. L. Campeau, M. Enjalbert, J. Lesperance, M.G. Bourassa, P. Kwiterovich Jr., and S. Wacholder et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation: a study 10 years after aortocoronary bypass surgery N Engl J Med 311 1984 1329 1332
4. J.W. Kennedy, G.C. Kaiser, L.D. Fisher, C. Maynard, J.K. Fritz, and W. Myers et al. Multivariate discriminant analysis of the clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS) J Thorac Cardiovasc Surg 80 1980 876 887
5. M.E. Marenberg, N. Risch, L.F. Berkman, B. Floderus, and U. de Faire Genetic susceptibility to death from coronary heart disease in a study of twins N Engl J Med 330 1994 1041 1046
6. S. Deb, E.A. Cohen, S.K. Singh, D. Une, A. Laupacis, and S.E. Fremes Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery J Am Coll Cardiol 60 2012 28 35
7. D.W. Hosmer, and S. Lemeshow Applied Logistic Regression 1989 John Wiley & Sons New York
8. R. McPherson, J. Frohlich, G. Fodor, J. Genest Canadian Cardiovascular Society Canadian Cardiovascular Society position statement - recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease Can J Cardiol 22 2006 913 927
9. N.D. Desai, E.A. Cohen, C.D. Naylor, and S.E. Fremes A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts N Engl J Med 351 2004 2302 2309
10. J.H. Chesebro, I.P. Clements, V. Fuster, L.R. Elveback, H.C. Smith, and W.T. Bardsley et al. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency N Engl J Med 307 1982 73 78
11. S.J. Shah, D.D. Waters, P. Barter, J.J. Kastelein, J. Shepherd, and N.K. Wenger et al. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery J Am Coll Cardiol 51 2008 1938 1943
12. D.I. Buckley, R. Fu, M. Freeman, K. Rogers, and M. Helfand C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force Ann Intern Med 151 2009 483 495
13. S.E. Humphries, F. Drenos, G. Ken-Dror, and P.J. Talmud Coronary heart disease risk prediction in the era of genome-wide association studies: current status and what the future holds Circulation 121 2010 2235 2248
14. Fibrinogen Studies Collaboration Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis JAMA 294 2005 1799 1809
15. M. Woodward, A. Rumley, P. Welsh, S. MacMahon, and G. Lowe A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease J Thromb Haemost 5 2007 1795 1800
16. D.J. Gordon, J.L. Probstfield, R.J. Garrison, J.D. Neaton, W.P. Castelli, and J.D. Knoke et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies Circulation 79 1989 8 15
17. B.F. Culleton, M.G. Larson, P.W. Wilson, J.C. Evans, P.S. Parfrey, and D. Levy Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency Kidney Int 56 1999 2214 2219
18. J.F. Mann, H.C. Gerstein, J. Pogue, J. Bosch, and S. Yusuf Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 2001 629 636
19. CARDIoGRAM Consortium N.J. Samani Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease Nat Genet 43 2011 333 338
20. A. Helgadottir, G. Thorleifsson, A. Manolescu, S. Gretarsdottir, T. Blondal, and A. Jonasdottir et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction Science 316 2007 1491 1493
21. R. McPherson Chromosome 9p21 and coronary artery disease N Engl J Med 362 2010 1736 1737
22. Y. Yang, M.B. Trent, N. He, S.D. Lick, P. Zimniak, and Y.C. Awasthi et al. Glutathione-S-transferase A4-4 modulates oxidative stress in endothelium: possible role in human atherosclerosis Atherosclerosis 173 2004 211 221
23. Y. Yang, Y. Yang, Y. Xu, S.D. Lick, Y.C. Awasthi, and P.J. Boor Endothelial glutathione-S-transferase A4-4 protects against oxidative stress and modulates iNOS expression through NF-kappaB translocation Toxicol Appl Pharmacol 230 2008 187 196
24. J.H. Alexander, G. Hafley, R.A. Harrington, E.D. Peterson, T.B. Ferguson Jr., and T.J. Lorenz et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial JAMA 294 2005 2446 2454